Transmural Systems LLC
Andover, MA
- UEI
- NVTWAUS1JEH5
- CAGE
- 63ZX1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Dundee Park Dr, Andover, MA 01810, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$2,017,750 |
| FY2025 | -$157,516 |
| FY2024 | -$110,000 |
| FY2023 | $8,997,996 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Phase IIB transmural systems transcatheter cavopulmonary bypass endograft | National Heart Lung and Blood Institute (NIH) | $4,542,179 | |
| Closure device for transcaval access to the abdominal aorta | National Heart Lung and Blood Institute (NIH) | $2,988,033 |
Similar vendors
About the company
Transmural Systems LLC is a woman-owned small business that provides medical device research, development, and manufacturing services to federal agencies, focused on cardiovascular devices.
Through past federal contracts, Transmural Systems has conducted research and development on various catheter-based cardiovascular devices, including transcatheter shunt systems, intramyocardial suture annuloplasty systems, transcatheter repair systems for ventricular defects, MRI-compatible needles and guidewires, and myocardial biopsy devices. These contracts were awarded by the National Institutes of Health and National Heart, Lung, and Blood Institute, primarily through the Small Business Innovation Research program. Awards were set aside for Woman-Owned Small Businesses or total small business participation, with Transmural Systems serving as the prime contractor.
Transmural Systems has also received federal grants to support continued research and development of a Transcatheter Cavopulmonary Bypass Endograft device for treating congenital heart disease. A Phase IIB project grant was awarded by the National Heart, Lung, and Blood Institute to conduct preclinical testing and an Early Feasibility Study of this endograft device in human patients. The goal is to obtain FDA approval for expanded clinical trials and commercialization.
Quick answers
Is Transmural Systems LLC registered in SAM.gov?
Yes. Transmural Systems LLC's SAM.gov registration is active through November 10, 2026.
How much has Transmural Systems LLC received in federal contracts?
Federal contracts obligated $6,712,730 to Transmural Systems LLC in fiscal years 2023 through 2027.
What is Transmural Systems LLC's most recent federal award?
Transmural Systems LLC's most recent federal contract award is Award sbir topic #110 phase II-MRI myocardial biopsy system (75N92023C00024), from National Heart Lung and Blood Institute (NIH), on September 28, 2023.
On GovTribe
See Transmural Systems LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors